SIREN : 884600180
BIOVIVA & CO is a French company founded 5 years ago, specialized in the sector Activités des sièges sociaux. Based in SAINT-VINCENT-DE-BARBEYRARGUES (34730), this company of category PME shows in 2025 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1 335 718 € | 1 327 466 € | 1 160 799 € | 1 452 511 € | 885 831 € |
| Net income | 845 964 € | 94 071 € | 2 801 334 € | 169 883 € | 79 719 € |
| EBITDA | 74 338 € | -62 678 € | -70 890 € | 232 305 € | 122 249 € |
| Net margin | 63.3% | 7.1% | 241.3% | 11.7% | 9.0% |
In 2025, BIOVIVA & CO achieves revenue of 1.3 M€. Over the period 2021-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +10.8%. Vs 2024: +1%. After deducting consumption (0 €), gross margin stands at 1.3 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 74 k€, representing 5.6% of revenue. Positive scissor effect: EBITDA margin improves by +10.3 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 846 k€, i.e. 63.3% of revenue. This profit can be retained or distributed to shareholders.
1 335 718 €
1 335 718 €
74 338 €
73 785 €
845 964 €
5.6%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 95%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 63.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.044%
95.067%
63.375%
0.004
In 2025, the debt ratio of BIOVIVA & CO (0.04) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of BIOVIVA & CO (95.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2025, the repayment capacity of BIOVIVA & CO (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 939.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
939.756
0.0
In 2025, the liquidity ratio of BIOVIVA & CO (939.76) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of BIOVIVA & CO (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 118 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 37 days. The gap of 81 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 623 days of revenue, i.e. 2.3 M€ to permanently finance. Over 2021-2025, WCR increased by +422%, requiring additional financing.
2 312 502 €
118 j
37 j
0 j
623 j
Based on 54 transactions of similar company sales
in 2025,
the value of BIOVIVA & CO is estimated at
760 307 €
(range 268 093€ - 1 342 920€).
With an EBITDA of 74 338€, the sector multiple of 1.1x is applied.
The price/revenue ratio is 0.63x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOVIVA & CO with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of BIOVIVA & CO in 2025 is 1.3 M€.
Yes, BIOVIVA & CO generated a net profit of 846 k€ in 2025.
The headquarters of BIOVIVA & CO is located in SAINT-VINCENT-DE-BARBEYRARGUES (34730), in the department Herault.
The tax return of BIOVIVA & CO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOVIVA & CO operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.